CGEN vs OABI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 28, 2026

CGEN

65.1
AI Score
VS
CGEN Wins

OABI

53.4
AI Score

Investment Advisor Scores

CGEN

65score
Recommendation
STRONG BUY

OABI

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CGEN OABI Winner
Forward P/E 12.3609 0 Tie
PEG Ratio 1.2874 0 Tie
Revenue Growth 107.0% 244.2% OABI
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 65.1/100 53.4/100 CGEN
Profit Margin 47.6% -115.1% CGEN
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY HOLD CGEN

Relative Price Performance (Last 90 Days)

CGEN 1M: -15.5% · 3M: -12.1% OABI 1M: +4.6% · 3M: +154.4%

Current Technical Phase

CGEN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.3%), weak momentum, RSI 40

RSI (14): 39.6 · Price: $1.97

OABI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (24.2% over 20 days), RSI 58

RSI (14): 57.7 · Price: $4.96

Fundamentals Snapshot

Metric CGEN OABI
Market Cap — —
Forward P/E -5.4 -17.0
Trailing P/E 4.9 —
Revenue (TTM) — —
Revenue Growth 1.1% 2.4%
Gross Margin 0.9% 1.0%
Operating Margin -3.4% -0.5%
EPS 0.38 -0.36
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CGEN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.